{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T12:50:32Z","timestamp":1766407832896},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,7,17]],"date-time":"2007-07-17T00:00:00Z","timestamp":1184630400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1007\/s10792-007-9103-4","type":"journal-article","created":{"date-parts":[[2007,7,16]],"date-time":"2007-07-16T22:45:28Z","timestamp":1184625928000},"page":"23-28","source":"Crossref","is-referenced-by-count":10,"title":["Hyperhomocysteinemia and central retinal vein occlusion in Iranian population"],"prefix":"10.1007","volume":"28","author":[{"given":"Sasan","family":"Moghimi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Najmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hooshang","family":"Faghihi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Karkhaneh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Sadegh","family":"Farahvash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Maghsoudipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,7,17]]},"reference":[{"key":"9103_CR1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0268-960X(98)90027-3","volume":"12","author":"J Townend","year":"1998","unstructured":"Townend J, O\u2019Sullivan J, Wilde JT (1998) Hyperhomocysteinemia and vascular disease. Blood Rev 12:23\u201334","journal-title":"Blood Rev"},{"key":"9103_CR2","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/ajcp\/106.6.709","volume":"105","author":"SC Guba","year":"1996","unstructured":"Guba SC, Fink LM, Fonseca V (1996) Hyperhomocysteinemia: an emerging and important risk factor for thromboembolic and cardiovascular disease. Am J Clin Pathol 105:709\u2013722","journal-title":"Am J Clin Pathol"},{"issue":"9043","key":"9103_CR3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(97)80014-1","volume":"349","author":"G Alfthan","year":"1997","unstructured":"Alfthan G, Aro A, Gey KF (1997) Plasma homocysteine and cardiovascular disease mortality. Lancet 349(9043):397","journal-title":"Lancet"},{"key":"9103_CR4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ng0595-111","volume":"10","author":"P Frosst","year":"1995","unstructured":"Frosst P, Blom HJ, Milos R et al (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111\u2013113","journal-title":"Nat Genet"},{"key":"9103_CR5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/ajcn\/67.2.263","volume":"67","author":"O Nyg\u00e5rd","year":"1998","unstructured":"Nyg\u00e5rd O, Refsum H, Ueland PM et al (1998) Major lifestyle determinants of plasma homocysteine distribution: the Hordaland Homocysteine Study. Am J Clin Nutr 67:263\u2013270","journal-title":"Am J Clin Nutr"},{"key":"9103_CR6","first-page":"441","volume":"25","author":"SL Morgan","year":"1998","unstructured":"Morgan SL, Baggott JE, Lee JY et al (1998) Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during long-term, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention. J Rheumatol 25:441\u2013446","journal-title":"J Rheumatol"},{"key":"9103_CR7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev.med.49.1.31","volume":"49","author":"H Refsum","year":"1998","unstructured":"Refsum H, Ueland PM, Nygard O et al (1998) Homocysteine and cardiovascular disease. Ann Rev Med 49:31\u201362","journal-title":"Ann Rev Med"},{"key":"9103_CR8","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1001\/jama.1993.03510220049033","volume":"270","author":"J Selhub","year":"1993","unstructured":"Selhub J, Jacques PF, Wilson PW et al (1993) Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 270:2693\u20132698","journal-title":"JAMA"},{"key":"9103_CR9","first-page":"520","volume":"15","author":"MI Salahuddin","year":"2005","unstructured":"Salahuddin MI, Ahmed SI (2005) Homocysteine level in patients with established transmural myocardial infarction. J Coll Physicians Surg Pak 15:520\u2013523","journal-title":"J Coll Physicians Surg Pak"},{"key":"9103_CR10","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0049-3848(03)00242-1","volume":"109","author":"M Ogawa","year":"2003","unstructured":"Ogawa M, Abe S, Saigo M et al (2003) Homocysteine and hemostatic disorder as a risk factor for myocardial infarction at a young age. Thromb Res 109:253\u2013258","journal-title":"Thromb Res"},{"key":"9103_CR11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1179\/016164106X91834","volume":"28","author":"H Wang","year":"2006","unstructured":"Wang H, Fan D, Zhang H et al (2006) Serum level of homocysteine is correlated to carotid artery atherosclerosis in Chinese with ischemic stroke. Neurol Res 28:25\u201330","journal-title":"Neurol Res"},{"key":"9103_CR12","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/01.hjr.0000160834.75466.b0","volume":"12","author":"JK Virtanen","year":"2005","unstructured":"Virtanen JK, Voutilainen S, Happonen P et al (2005) Serum homocysteine, folate and risk of stroke: Kuopio Ischaemic Heart Disease Risk Factor (KIHD) Study. Eur J Cardiovasc Prev Rehabil 12:369\u2013375","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"9103_CR13","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1161\/01.CIR.87.4.1107","volume":"87","author":"MR Malinow","year":"1993","unstructured":"Malinow MR, Nieto FJ, Szklo M et al (1993) Carotid artery intimal-medial wall thickening and plasma homocysteine in asymptomatic adults: the Atherosclerosis Risk in Communities Study. Circulation 87:1107\u20131113","journal-title":"Circulation"},{"key":"9103_CR14","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0002-9394(99)00476-6","volume":"129","author":"AK Vine","year":"2000","unstructured":"Vine AK (2000) Hyperhomocysteinemia: a risk factor for central retinal vein occlusion. Am J Ophthalmol 129:640\u2013644","journal-title":"Am J Ophthalmol"},{"key":"9103_CR15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ajo.2004.06.084","volume":"139","author":"B Chua","year":"2005","unstructured":"Chua B, Kifley A, Wong TY et al (2005) Homocysteine and retinal vein occlusion: a population-based study. Am J Ophthalmol 139:181\u2013182","journal-title":"Am J Ophthalmol"},{"key":"9103_CR16","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1177\/112067210201200608","volume":"12","author":"AM Abu El-Asrar","year":"2002","unstructured":"Abu El-Asrar AM, Abdel Gader AG, Al-Amro SA et al (2002) Hyperhomocysteinemia and retinal vascular occlusive disease. Eur J Ophthalmol 12:495\u2013500","journal-title":"Eur J Ophthalmol"},{"key":"9103_CR17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1477-9560-3-13","volume":"3","author":"P Terrazzi","year":"2005","unstructured":"Terrazzi P, Di Micco P, Quaglia I et al (2005) Homocysteine, MTHFR C677T gene polymorphism, folic acid and vitamin B 12 in patients with retinal vein occlusion. Thromb J 3:13","journal-title":"Thromb J"},{"key":"9103_CR18","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000076144","volume":"218","author":"C Yildirim","year":"2004","unstructured":"Yildirim C, Yaylali V, Tatlipinar S et al (2004) Hyperhomocysteinemia: a risk factor for retinal vein occlusion. Ophthalmologica 218:102\u2013106","journal-title":"Ophthalmologica"},{"key":"9103_CR19","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s00417-002-0431-9","volume":"240","author":"M Weger","year":"2002","unstructured":"Weger M, Stanger O, Deutschmann H et al (2002) Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 240:286\u2013290","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"9103_CR20","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/bjo.85.1.88","volume":"85","author":"M Cahill","year":"2001","unstructured":"Cahill M, Karabatzaki M, Donoghue C et al (2001) Thermolabile MTHFR genotype and retinal vascular occlusive disease. Br J Ophthalmol 85:88\u201390","journal-title":"Br J Ophthalmol"},{"key":"9103_CR21","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/eye.2000.148","volume":"14","author":"SC Martin","year":"2000","unstructured":"Martin SC, Raiz S, Marr JE et al (2000) Plasma total homocysteine and retinal vascular disease. Eye 14:590\u2013593","journal-title":"Eye"},{"key":"9103_CR22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0161-6420(01)00923-X","volume":"109","author":"BA Brown","year":"2002","unstructured":"Brown BA, Marx JL, Ward TP et al (2002) Homocysteine: a risk factor for retinal venous occlusive disease. Ophthalmology 109:287\u2013290","journal-title":"Ophthalmology"},{"key":"9103_CR23","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1136\/bjo.85.11.1313","volume":"85","author":"S Boyd","year":"2001","unstructured":"Boyd S, Owens D, Gin T et al (2001) Plasma homocysteine,methylene tetrahydrofolate redoctase C677T and factor II G20210A polymorphisms, factor VIII, and VWF in central retinal vein occlusion. Br J Ophthalmol 85:1313\u20131315","journal-title":"Br J Ophthalmol"},{"key":"9103_CR24","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/S0161-6420(00)00181-0","volume":"107","author":"P Pianka","year":"2000","unstructured":"Pianka P, Almog Y, Man O et al (2000) Hyperhomocystinemia in patients with nonarteritic anterior ischemic optic neuropathy, central retinal artery occlusion and central retinal vein occlusion. Ophthalmology 107:1588\u20131592","journal-title":"Ophthalmology"},{"key":"9103_CR25","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1034\/j.1600-0420.2000.078003340.x","volume":"78","author":"J Larsson","year":"2000","unstructured":"Larsson J, Hultberg B, Hillarp (2000) Hyperhomocysteinemia and the MTHF C677T mutation in central retinal vein occlusion. Acta Ophthalmol Scand 78:340\u2013343","journal-title":"Acta Ophthalmol Scand"},{"key":"9103_CR26","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1167\/iovs.06-0290","volume":"47","author":"A Pinna","year":"2006","unstructured":"Pinna A, Carru C, Zinellu A (2006) Plasma homocysteine and cysteine levels in retinal vein occlusion. Invest Ophthalmol Vis Sci 47:4067\u20136071","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9103_CR27","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1167\/iovs.04-1229","volume":"46","author":"SJ McGimpsey","year":"2005","unstructured":"McGimpsey SJ, Woodside JV, Bamford L et al (2005) Retinal vein occlusion, homocysteine, and methylene tetrahydrofolate reductase genotype. Invest Ophthalmol Vis Sci 46:4712\u20134716","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9103_CR28","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.ophtha.2003.08.028","volume":"111","author":"L Di Crecchio","year":"2004","unstructured":"Di Crecchio L, Parodi MB, Sanguinetti G et al (2004) Hyperhomocysteinemia and the methylenetetrahydrofolate reductase 677C-T mutation in patients under 50 years of age affected by central retinal vein occlusion. Ophthalmology 111:940\u2013945","journal-title":"Ophthalmology"},{"key":"9103_CR29","first-page":"139","volume":"28","author":"J Golbahar","year":"2003","unstructured":"Golbahar J, Bararpour H (2003) Normal range of total plasma homocysteine concentrations in southern Iran. IJMS 28:139\u2013142","journal-title":"IJMS"},{"key":"9103_CR30","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.1997.03540460039030","volume":"277","author":"IM Graham","year":"1997","unstructured":"Graham IM, Daly LE, Refsum HM et al (1997) Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 277:1775\u20131781","journal-title":"JAMA"},{"key":"9103_CR31","first-page":"371","volume":"79","author":"WR Green","year":"1981","unstructured":"Green WR, Chan CC, Hutchins GM et al (1981) Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Trans Am Ophthalmol Soc 79:371\u2013422","journal-title":"Trans Am Ophthalmol Soc"},{"key":"9103_CR32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00006982-200601000-00011","volume":"26","author":"R Lattanzio","year":"2006","unstructured":"Lattanzio R, Sampietro F, Ramoni A et al (2006) Moderate hyperhomocysteinemia and early-onset central retinal vein occlusion. Retina 26:65\u201370","journal-title":"Retina"},{"key":"9103_CR33","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1007\/s00417-005-0191-4","volume":"244","author":"W Gao","year":"2006","unstructured":"Gao W, Wang YS, Zhang P et al (2006) Hyperhomocysteinemia and low plasma folate as risk factors for central retinal vein occlusion: a case-control study in a Chinese population. Graefes Arch Clin Exp Ophthalmol 244:1246\u20131249","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"9103_CR34","unstructured":"Cugati S, Wang JJ, Knudtson MD et al (2006) Retinal Vein Occlusion and Vascular Mortality Pooled Data Analysis of 2 Population-Based Cohorts. Ophthalmology.;29 [Epub ahead of print]"},{"key":"9103_CR35","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/eye.2000.230","volume":"14","author":"MD Tsaloumas","year":"2000","unstructured":"Tsaloumas MD, Kirwan J, Vinall H et al (2000) Nine year follow-up study of morbidity and mortality in retinal vein occlusion. Eye 14:821\u2013827","journal-title":"Eye"},{"key":"9103_CR36","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0021-9150(98)00273-1","volume":"143","author":"R Griend Van der","year":"1999","unstructured":"Van der Griend R, Haas FJ, Biesma DH et al (1999) Combination of low-dose folic acid and pyridoxine for treatment of hyperhomocysteinemia in patients with premature arterial disease and their relatives. Atherosclerosis 143:177\u2013183","journal-title":"Atherosclerosis"},{"key":"9103_CR37","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1086\/302439","volume":"65","author":"LA Kluijtmans","year":"1999","unstructured":"Kluijtmans LA, Boers GH, Kraus JP et al (1999) The molecular basis of cystathionine beta-synthase deficiency in Dutch patients with homocystinuria: effect of CBS genotype on biochemical and clinical phenotype and on response to treatment. Am J Hum Genet 65:59\u201367","journal-title":"Am J Hum Genet"},{"key":"9103_CR38","first-page":"242","volume":"59","author":"JW Miller","year":"2001","unstructured":"Miller JW (2001) Does lowering plasma homocysteine reduce vascular disease risk? Nutr Rev 59:242\u2013244","journal-title":"Nutr Rev"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-007-9103-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10792-007-9103-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-007-9103-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T20:24:09Z","timestamp":1559247849000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10792-007-9103-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7,17]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["9103"],"URL":"https:\/\/doi.org\/10.1007\/s10792-007-9103-4","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7,17]]}}}